- List of Included Studies - ADHD Diagnosis and Treatment in Children and Adolescents - NCBI Bookshelf... F, et al. Behavioral and cognitive effects of docosahexaenoic acid in drug-naïve children with attention-deficit/hyperactivity ... A randomized, double-blind, placebo-controlled trial of docosahexaenoic acid supplementation in children with attention-deficit/hyperactivity disorder. ...
- ... Engler MB, Malloy MJ, et al. Effect of docosahexaenoic acid on lipoprotein subclasses in hyperlipidemic children (the EARLY ... Engler MM, Engler MB, Arterburn LM, et al. Docosahexaenoic acid supplementation alters plasma phospholipid fatty acid composition in ...
- ... Matsuoka Y, Nishi D, Hamazaki K, et al. Docosahexaenoic acid for selective prevention of posttraumatic stress disorder among ... BDNF as a treatment biomarker for response to docosahexaenoic acid in traumatized people vulnerable to developing psychological distress: ...
- ... Quinn JF, Raman R, Thomas RG, et al. Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a ... D, Rom D, et al. Beneficial effects of docosahexaenoic acid on cognition in age-related cognitive decline. Alzheimers ...
- ... Matsuoka Y, Nishi D, Hamazaki K, et al. Docosahexaenoic acid for selective prevention of posttraumatic stress disorder among ... BDNF as a treatment biomarker for response to docosahexaenoic acid in traumatized people vulnerable to developing psychological distress: ...
- ... taking vitamin A. Omega 3 supplements (e.g., docosahexaenoic acid [DHA]) may replenish membranes of the photoreceptor outer ... Klein M, Takacs A, Locke KG, Birch DG. Docosahexaenoic acid slows visual field progression in X-linked retinitis ...
- ... taking vitamin A. Omega 3 supplements (e.g., docosahexaenoic acid [DHA]) may replenish membranes of the photoreceptor outer ... Klein M, Takacs A, Locke KG, Birch DG. Docosahexaenoic Acid Slows Visual Field Progression in X-Linked Retinitis ...
- ... dependent on the: Specific type of fatty acid (docosahexaenoic acid [DHA, 22:6 n‐3], eicosapentaenoic acid [EPA, ... any secondary prevention studies. Question 6 (Impact on Safety) Eight RCTs and two studies employing other designs ...
- ... that one formulation of omega-3 fatty acids (docosahexaenoic acid [DHA] 675 mg + eicosapentaenoic acid (EPA) 975 mg/ ... the caregiver’s emotional or psychological issues), home safety assessments or information, occupational therapy, and environmental modifications. ...
- ... randomized controlled clinical trial comparing eicosapentaenoic acid versus docosahexaenoic acid for depression. J Clin Psychiatry. 2014 Sep 16 ... Mansuy L, Ruth A, et al. Efficacy and safety of levomilnacipran sustained release in moderate to severe ...